Novo Nordisk (NVO)

Novo Nordisk (NVO) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• NVO last traded at $40.66, 1.65% on the day.
• Novo Nordisk: market cap $176.43B, P/E 10.3, revenue $329.43B over the last four quarters, next earnings 2026-11-04.
• Over the past year NVO returned -18.75%; year to date -20.09%.

Updated 2026-11-02 17:12 UTC